He is currently involved in the characterization of molecular aspects of brain development relevant to the Canavan Disease phenotype, which aims to identify the fundamental regulatory mechanism responsible for disease progression in affected individuals. He is also investigating aspects of the immune response in the brain with application to neurodegenerative autoimmune disorders.